Journal
Blood Cancer Journal
Publication Date
7-19-2022
Volume
12
Issue
7
First Page
110
Document Type
Open Access Publication
DOI
10.1038/s41408-022-00704-7
Rights and Permissions
Weisberg, E., Chowdhury, B., Meng, C. et al. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. Blood Cancer J. 12, 110 (2022). https://doi.org/10.1038/s41408-022-00704-7This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Weisberg, Ellen; Azab, Abdel Kareem; Sun, Jennifer; Muz, Barbara; and et al, "BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma." Blood Cancer Journal. 12, 7. 110 (2022).
https://digitalcommons.wustl.edu/oa_4/190
Supplementary Figure Legends- clean
41408_2022_704_MOESM2_ESM.pdf (1123 kB)
Supplementary Figures 1-12
41408_2022_704_MOESM3_ESM.doc (57 kB)
Supplementary Table 1-Primary Patient Information
